NYSE · Consumer Defensive · Household & Personal Products · USA
Kenvue Inc is a large cap company (market value between $10 billion and $200 billion) in the Household & Personal Products industry.
Kenvue is a global consumer health company offering over-the-counter medicines, skincare, and personal care products through iconic brands including Tylenol, Listerine, Aveeno, and Johnson's. The company distributes across three product categories—pain and cold remedies, dermatological solutions, and essential care items—to North America, Asia Pacific, Europe, Middle East, Africa, and Latin America.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Kenvue Inc stock.
Overvalued: intrinsic value $13.02 per share, market price $18.87, margin of safety -44.9% (as of 2026-10-19).
Discounting its cash flows at 7.4% (average of 3 methods) values the shares at $13.02; the price of $18.87 is 45% above that value, and 81% of that value comes from beyond year five.
Leak Score: 26/100 on 7 of 12 signals (On Watch).
17 more funds hold it; the full list is part of the paid plan.
All 30 Household & Personal Products stocks
1 more in this industry show a wider margin of safety.
KVUE is overvalued (as of the 2026-10-19 close). Discounting its cash flows at 7.4% (average of 3 methods) values the shares at $13.02; the price of $18.87 is 45% above that value, and 81% of that value comes from beyond year five.
$13.02 per share (as of the 2026-10-19 close), against a market price of $18.87. That is a margin of safety of -44.9%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
26 out of 100, which we rate "On Watch", on 7 of 12 value investing signals.